Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S P Moore

Showing results (121-130 of 176) with videos related to

Pageof 18
Sort By:
BMC Infectious Diseases|June 12, 2021
Bacteraemia variation during the COVID-19 pandemic; a multi-centre UK secondary care ecological analysisSarah Denny, Timothy M Rawson, Peter Hart, et al.
BMJ Open|November 2, 2016
Patient engagement with infection management in secondary care: a qualitative investigation of current experiencesTimothy M Rawson, Luke S P Moore, Bernard Hernandez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 17, 2020
Reply to Dudoignon et alTimothy M Rawson, Luke S P Moore, Nina Zhu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 3, 2020
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial PrescribingTimothy M Rawson, Luke S P Moore, Nina Zhu, et al.
Journal of Global Antimicrobial Resistance|July 27, 2020
Validating a prediction tool to determine the risk of nosocomial multidrug-resistant Gram-negative bacilli infection in critically ill patients: A retrospective case-control studySara E Boyd, Anupama Vasudevan, Luke S P Moore, et al.
Expert Review of Anti-Infective Therapy|August 7, 2024
Nirmatrelvir/ritonavir: real world drug-drug interaction management experienceShahid Bukhari, Stephen Hughes, Nabeela Mughal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 29, 2026
Assessment of the Prioritization of Diagnostics in National Action Plans for Antimicrobial ResistanceGeorgia Lamb, Scott J C Pallett, Esmita Charani, et al.
Scientific Reports|March 13, 2021
Point-of-care SARS-CoV-2 serological assays for enhanced case finding in a UK inpatient populationS J C Pallett, S J Denny, A Patel, et al.
The Journal of Antimicrobial Chemotherapy|August 14, 2014
Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108,717 clinical isolates from primary, secondary and tertiary care patients in LondonLuke S P Moore, Rachel Freeman, Mark J Gilchrist, et al.
Lancet (London, England)|November 26, 2015
Understanding the mechanisms and drivers of antimicrobial resistanceAlison H Holmes, Luke S P Moore, Arnfinn Sundsfjord, et al.
Pageof 18

Showing results (121-130 of 176) with videos related to

Sort By:
Pageof 18
BMC Infectious Diseases|June 12, 2021
Bacteraemia variation during the COVID-19 pandemic; a multi-centre UK secondary care ecological analysisSarah Denny, Timothy M Rawson, Peter Hart, et al.
BMJ Open|November 2, 2016
Patient engagement with infection management in secondary care: a qualitative investigation of current experiencesTimothy M Rawson, Luke S P Moore, Bernard Hernandez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 17, 2020
Reply to Dudoignon et alTimothy M Rawson, Luke S P Moore, Nina Zhu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 3, 2020
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial PrescribingTimothy M Rawson, Luke S P Moore, Nina Zhu, et al.
Journal of Global Antimicrobial Resistance|July 27, 2020
Validating a prediction tool to determine the risk of nosocomial multidrug-resistant Gram-negative bacilli infection in critically ill patients: A retrospective case-control studySara E Boyd, Anupama Vasudevan, Luke S P Moore, et al.
Expert Review of Anti-Infective Therapy|August 7, 2024
Nirmatrelvir/ritonavir: real world drug-drug interaction management experienceShahid Bukhari, Stephen Hughes, Nabeela Mughal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 29, 2026
Assessment of the Prioritization of Diagnostics in National Action Plans for Antimicrobial ResistanceGeorgia Lamb, Scott J C Pallett, Esmita Charani, et al.
Scientific Reports|March 13, 2021
Point-of-care SARS-CoV-2 serological assays for enhanced case finding in a UK inpatient populationS J C Pallett, S J Denny, A Patel, et al.
The Journal of Antimicrobial Chemotherapy|August 14, 2014
Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108,717 clinical isolates from primary, secondary and tertiary care patients in LondonLuke S P Moore, Rachel Freeman, Mark J Gilchrist, et al.
Lancet (London, England)|November 26, 2015
Understanding the mechanisms and drivers of antimicrobial resistanceAlison H Holmes, Luke S P Moore, Arnfinn Sundsfjord, et al.
Pageof 18